vadimezan has been researched along with Bone Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bang, S; Donnelly, CR; Hilton, MJ; Ji, RR; Jiang, C; Lee, M; Liao, Y; Luo, X; McGinnis, A; Tao, X; Wang, K | 1 |
Cathomas, R; Erdmann, A; Früh, M; Fustier, P; Krasniqi, F; Küttel, E; Mamot, C; Pless, M; Rauch, D; Siano, M; Simcock, M; Tscherry, G; Zippelius, A | 1 |
1 trial(s) available for vadimezan and Bone Cancer
Article | Year |
---|---|
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Small Cell Lung Carcinoma; Treatment Outcome; Xanthones | 2013 |
1 other study(ies) available for vadimezan and Bone Cancer
Article | Year |
---|---|
STING suppresses bone cancer pain via immune and neuronal modulation.
Topics: Analgesics; Animals; Bone Neoplasms; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Female; Femur; Ganglia, Spinal; Homeodomain Proteins; Hyperalgesia; Interferons; Male; Mammary Neoplasms, Animal; Membrane Proteins; Mice, Inbred C57BL; Neoplasm Metastasis; Neurons; Nociception; Osteoclasts; Osteogenesis; Receptor, Interferon alpha-beta; Signal Transduction; Tumor Burden; Tumor Microenvironment; Xanthones | 2021 |